Evidence map›Paper›PMID 35089449›Full record

Trial reportAIDS and behavior2022

Real-World User Experiences with a Digital Pill System to Measure PrEP Adherence: Perspectives from MSM with Substance Use.

Peter R Chai, Georgia R Goodman, Olivia Bronzi, Gerard Gonzales, Alejandro Baez, Maria J Bustamante, Jesse Najarro, Yassir Mohamed, Matthew C Sullivan, Kenneth H Mayer and 3 more

Registry-linked trialOpen access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in AIDS and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03842436 (Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03842436 phase4completednot on this map

Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use

TypeinterventionalSponsorBrigham and Women's HospitalRan2018 to 2020Enrolled16ConditionsHIV/AIDS, Substance Use Disorders, Adherence, MedicationArmsDigital pill, Truvada
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Real-World Implementation Challenges Associated with a Digital Pill System to Measure Adherence to HIV Pre-Exposure Prophylaxis from Two Studies of Men Who Have Sex With Men.Proceedings of the ... Annual Hawaii International Conference on System Sciences. Annual Hawaii International Conference on System Sciences · 2024
    Article
  11. Preliminary feasibility of a wrist-worn receiver to measure medication adherence via an ingestible radiofrequency sensor.... International Conference on Wearable and Implantable Body Sensor Networks. International Conference on Wearable and Implantable Body Sensor Networks · 2023
    Article
  12. Diversity in Digital Pill Systems: Differences in Perceptions and Attitudes Towards Use of a Digital Pill System for HIV Pre-Exposure Prophylaxis Among Men Who Have Sex with Men with Diverse Racial and Ethnic Identities.Proceedings of the ... Annual Hawaii International Conference on System Sciences. Annual Hawaii International Conference on System Sciences · 2023
    Article
  13. Article
  14. Digital Pills with Ingestible Sensors: Patent Landscape Analysis.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Peter R ChaiDepartment of Emergency Medicine, Brigham and Women's Hospital, 75 Francis St., Boston, MA, 02411, USA. pchai@bwh.harvard.edu.ORCID http://orcid.org/0000-0003-0955-4117
Georgia R GoodmanDepartment of Emergency Medicine, Brigham and Women's Hospital, 75 Francis St., Boston, MA, 02411, USA.
Olivia BronziThe Fenway Institute, Fenway Health, Boston, MA, USA.
Gerard GonzalesThe Fenway Institute, Fenway Health, Boston, MA, USA.
Alejandro BaezThe Fenway Institute, Fenway Health, Boston, MA, USA.
Maria J BustamanteThe Fenway Institute, Fenway Health, Boston, MA, USA.
Jesse NajarroThe Fenway Institute, Fenway Health, Boston, MA, USA.
Yassir MohamedThe Fenway Institute, Fenway Health, Boston, MA, USA.
Matthew C SullivanThe Fenway Institute, Fenway Health, Boston, MA, USA.
Kenneth H MayerThe Fenway Institute, Fenway Health, Boston, MA, USA.
Edward W BoyerDepartment of Emergency Medicine, Brigham and Women's Hospital, 75 Francis St., Boston, MA, 02411, USA.
Conall O'CleirighThe Fenway Institute, Fenway Health, Boston, MA, USA.
Rochelle K RosenCenter for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, RI, USA.
Fenway Health · USBrigham and Women's Hospital · USMassachusetts General Hospital · USBeth Israel Deaconess Medical Center · USBrown University · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ARTHUR Y KIM · 2004 to 2026
$94.4M
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence among HIV+ Prescription Opioid UsersR01DA047236 · NIDA · OHIO STATE UNIVERSITY · PI BOYER, EDWARD W, CARRICO, ADAM WAYNE · 2019 to 2022
$3.0M
A novel robotic wastewater analysis system to quantify opioid exposure and treatment in residential communitiesR44DA051106 · NIDA · BIOBOT ANALYTICS, INC. · PI CHAI, PETER R, MATUS GARCIA, MARIANA G · 2020 to 2022
$1.5M
Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance UsersK23DA044874 · NIDA · BRIGHAM AND WOMEN'S HOSPITAL · PI CHAI, PETER R · 2018 to 2022
$1.0M
NIDA National Early Warning System Network (iN3): An Innovative ApproachR56DA038366 · NIDA · WRIGHT STATE UNIVERSITY · PI BOYER, EDWARD W, CARLSON, ROBERT GEOFFREY · 2014 to 2014
$300k
Defense Advanced Research Projects Agency HR001120S0041Gates Foundation INV-002177Gilead Sciences ISR-17-10189National Institute of Allergy and Infectious Diseases P30AI060354NIAID NIH HHS P30 AI060354NIDA NIH HHS K23 DA044874NIDA NIH HHS K23DA044874NIDA NIH HHS R01 DA047236NIDA NIH HHS R01DA047236NIDA NIH HHS R44 DA051106NIDA NIH HHS R44DA051106NIDA NIH HHS R56 DA038366
6 · The paper itself

Abstract

Once-daily oral pre-exposure prophylaxis (PrEP) is highly effective for preventing HIV transmission, but adherence can be challenging for men who have sex with men (MSM) who use substances. A novel method for directly measuring ingestion events is a digital pill system (DPS), which comprises an ingestible radiofrequency emitter that signals a wearable Reader device upon PrEP ingestion, relaying ingestion data to a wearable Reader device and then to a smartphone application. Qualitative interviews were conducted with 15 MSM with non-alcohol substance use following an open-label pilot demonstration trial involving use of the DPS to measure PrEP adherence for 90 days. The purpose of this qualitative investigation was to understand overall user experiences and potential barriers and facilitators to using the DPS to measure PrEP adherence among MSM. The DPS was largely perceived as acceptable, novel, and valuable, with most participants reporting that the system was easily integrated into their daily routines. Technological and design factors, especially related to the wearable Reader, impacted participants' interest in using the technology long-term; several suggested improvements were discussed.Trial Registration ClinicalTrials.gov: NCT03842436.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisSexual and Gender MinoritiesSubstance-Related DisordersHomosexuality, MaleHumansMaleMedication AdherenceAnti-HIV AgentsAdherenceDigital pill systemHIV preventionIngestible sensorsPrEP

Identifiers

PMID35089449
PMCPMC8795732
OpenAlexW4210435457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.